Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics (Cancer Growth and Progression, 14) provides a comprehensive look at a decade of rapid advancements in the field. This volume covers the transition from basic molecular biology and pathology to modern clinical therapy. By bringing together insights from global experts, the book addresses current treatment approaches and the future of progress in malignant hematologic diseases. Readers can gain a deep understanding of the pathobiology behind these cancers through the lens of recent scientific breakthroughs. This text serves as a vital resource for those tracking the evolution of knowledge in hematology, moving from fundamental molecular research to the implementation of targeted therapeutic strategies in clinical settings.